![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TMEM45A |
Gene summary for TMEM45A |
![]() |
Gene information | Species | Human | Gene symbol | TMEM45A | Gene ID | 55076 |
Gene name | transmembrane protein 45A | |
Gene Alias | DERP7 | |
Cytomap | 3q12.2 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | Q9NWC5 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
55076 | TMEM45A | P83T-E | Human | Esophagus | ESCC | 1.36e-09 | 3.44e-01 | 0.1738 |
55076 | TMEM45A | P89T-E | Human | Esophagus | ESCC | 6.11e-13 | 8.42e-01 | 0.1752 |
55076 | TMEM45A | P91T-E | Human | Esophagus | ESCC | 2.19e-10 | 1.33e+00 | 0.1828 |
55076 | TMEM45A | P107T-E | Human | Esophagus | ESCC | 2.14e-15 | 4.82e-01 | 0.171 |
55076 | TMEM45A | P128T-E | Human | Esophagus | ESCC | 1.48e-20 | 6.91e-01 | 0.1241 |
55076 | TMEM45A | P130T-E | Human | Esophagus | ESCC | 3.40e-22 | 5.38e-01 | 0.1676 |
55076 | TMEM45A | NAFLD1 | Human | Liver | NAFLD | 2.19e-09 | 8.88e-01 | -0.04 |
55076 | TMEM45A | S43 | Human | Liver | Cirrhotic | 1.73e-02 | -1.06e-01 | -0.0187 |
55076 | TMEM45A | HCC1_Meng | Human | Liver | HCC | 1.87e-50 | 3.53e-01 | 0.0246 |
55076 | TMEM45A | HCC2 | Human | Liver | HCC | 3.02e-04 | 3.57e+00 | 0.5341 |
55076 | TMEM45A | S015 | Human | Liver | HCC | 4.90e-02 | 3.19e-01 | 0.2375 |
55076 | TMEM45A | S027 | Human | Liver | HCC | 1.67e-17 | 1.66e+00 | 0.2446 |
55076 | TMEM45A | S028 | Human | Liver | HCC | 7.61e-15 | 1.08e+00 | 0.2503 |
55076 | TMEM45A | S029 | Human | Liver | HCC | 2.25e-22 | 1.47e+00 | 0.2581 |
55076 | TMEM45A | C04 | Human | Oral cavity | OSCC | 1.23e-07 | 6.31e-01 | 0.2633 |
55076 | TMEM45A | C21 | Human | Oral cavity | OSCC | 7.43e-17 | 1.73e+00 | 0.2678 |
55076 | TMEM45A | C30 | Human | Oral cavity | OSCC | 2.58e-07 | 3.42e-01 | 0.3055 |
55076 | TMEM45A | C38 | Human | Oral cavity | OSCC | 1.45e-04 | 1.03e+00 | 0.172 |
55076 | TMEM45A | C43 | Human | Oral cavity | OSCC | 2.50e-25 | 6.63e-01 | 0.1704 |
55076 | TMEM45A | C46 | Human | Oral cavity | OSCC | 6.49e-05 | 3.33e-01 | 0.1673 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TMEM45A | SNV | Missense_Mutation | c.143G>A | p.Arg48Gln | p.R48Q | Q9NWC5 | protein_coding | deleterious(0.03) | benign(0.325) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
TMEM45A | SNV | Missense_Mutation | c.414C>G | p.Phe138Leu | p.F138L | Q9NWC5 | protein_coding | deleterious(0.04) | possibly_damaging(0.617) | TCGA-C5-A2LX-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | SD | |
TMEM45A | SNV | Missense_Mutation | novel | c.749N>C | p.Arg250Thr | p.R250T | Q9NWC5 | protein_coding | deleterious(0) | possibly_damaging(0.617) | TCGA-5M-AAT4-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD |
TMEM45A | SNV | Missense_Mutation | rs760669672 | c.378N>A | p.Met126Ile | p.M126I | Q9NWC5 | protein_coding | deleterious(0.04) | benign(0.003) | TCGA-G4-6628-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
TMEM45A | SNV | Missense_Mutation | novel | c.124N>A | p.Ser42Thr | p.S42T | Q9NWC5 | protein_coding | tolerated(0.07) | benign(0.007) | TCGA-A5-A2K5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMEM45A | SNV | Missense_Mutation | novel | c.731N>A | p.Thr244Asn | p.T244N | Q9NWC5 | protein_coding | tolerated(0.26) | benign(0.003) | TCGA-A5-A2K5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMEM45A | SNV | Missense_Mutation | rs201066091 | c.800N>A | p.Arg267Gln | p.R267Q | Q9NWC5 | protein_coding | tolerated(0.14) | benign(0.051) | TCGA-AJ-A3EL-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TMEM45A | SNV | Missense_Mutation | c.540N>T | p.Glu180Asp | p.E180D | Q9NWC5 | protein_coding | deleterious(0.01) | probably_damaging(0.913) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TMEM45A | SNV | Missense_Mutation | c.34N>G | p.Thr12Ala | p.T12A | Q9NWC5 | protein_coding | deleterious(0.01) | benign(0.018) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
TMEM45A | SNV | Missense_Mutation | novel | c.280N>T | p.His94Tyr | p.H94Y | Q9NWC5 | protein_coding | deleterious(0.01) | possibly_damaging(0.642) | TCGA-AX-A1CE-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |